United Therapeutics (UTHR) Assets Average (2016 - 2025)
Historic Assets Average for United Therapeutics (UTHR) over the last 16 years, with Q3 2025 value amounting to $7.6 billion.
- United Therapeutics' Assets Average rose 1020.34% to $7.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 billion, marking a year-over-year increase of 1020.34%. This contributed to the annual value of $7.3 billion for FY2024, which is 998.75% up from last year.
- According to the latest figures from Q3 2025, United Therapeutics' Assets Average is $7.6 billion, which was up 1020.34% from $7.8 billion recorded in Q2 2025.
- In the past 5 years, United Therapeutics' Assets Average registered a high of $7.8 billion during Q2 2025, and its lowest value of $4.6 billion during Q1 2021.
- Over the past 5 years, United Therapeutics' median Assets Average value was $6.5 billion (recorded in 2023), while the average stood at $6.3 billion.
- Per our database at Business Quant, United Therapeutics' Assets Average skyrocketed by 2101.56% in 2023 and then skyrocketed by 103.17% in 2024.
- Over the past 5 years, United Therapeutics' Assets Average (Quarter) stood at $5.1 billion in 2021, then increased by 15.74% to $5.9 billion in 2022, then rose by 19.99% to $7.1 billion in 2023, then grew by 2.09% to $7.2 billion in 2024, then grew by 5.33% to $7.6 billion in 2025.
- Its Assets Average stands at $7.6 billion for Q3 2025, versus $7.8 billion for Q2 2025 and $7.6 billion for Q1 2025.